Volume 9, Number 12—December 2003
Noninvasive Method for Monitoring Pneumocystis carinii Pneumonia
||0.5 to 0.0005 pgs/rx
||12.5 to 1.25 x 10-5 ngs/rx
|OS||Undiluted to 1:8 dilution||0.973||-3.328||1.997||0.997|
aPCR, polymerase chain reaction; mtLSU, mitochondrial large ribosomal subunit RNA; LH, rat lung homogenate; OS, oral swab P. carinii–specific DNA; rx, reaction.
Page created: February 09, 2011
Page updated: February 09, 2011
Page reviewed: February 09, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.